Therapy News and Research

RSS

Researchers identify immune protein linked to rare neurodegenerative disease

UT Southwestern researchers have identified an immune protein tied to the rare neurodegenerative condition known as Niemann-Pick disease type C.

21 Jul 2021

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

21 Jul 2021

Experts develop consensus statement to help improve long-term well-being of people with HIV

Since antiretroviral therapy (ART) for HIV was introduced in 1996, AIDS-related morbidity and mortality has declined significantly.

21 Jul 2021

Researchers use information theory to monitor resistance mechanisms to targeted cancer therapy

One of the major challenges in modern cancer therapy is the adaptive response of cancer cells to targeted therapies: initially, these therapies are very often effective, then adaptive resistance occurs, allowing the tumor cells to proliferate again.

21 Jul 2021

Pilot trial assesses sensory stimulation as a treatment for improving mobility in stroke survivors

Keele University researchers have completed the first phase of trials for treatments which aim to improve outcomes for stroke survivors that are learning to walk again.

21 Jul 2021

World Brain Day 2021: An interview with Professor Alan Thompson

In commemoration of World Brain Day 2021, News-Medical spoke to renowned neurology expert Professor Alan Thompson about his incredible career in brain research.

21 Jul 2021

Study shows promise of combining radiation therapy with dendritic-cell vaccines for breast cancer

A research team led by Fumito Ito, MD, PhD, FACS, of Roswell Park Comprehensive Cancer Center reports new data on the promise of combining standard treatment for breast cancer with a particular form of cancer immmunotherapy - dendritic-cell (DC) treatment vaccines.

20 Jul 2021

MET amplification identified as a potentially actionable driver for non-small cell lung cancer

A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the University of Colorado School of Medicine and CU Cancer Center member, has helped to define MET amplification as a rare but potentially actionable driver for non-small cell lung cancer (NSCLC).

20 Jul 2021

Research reveals clues to how a molecule improves appearance of surgery scars

Surgical scars treated with a molecule called alphaCT1 showed a long-term improvement in appearance when compared to control scars, according to multicenter, controlled Phase II clinical trials - a finding that could help surgeons improve patient outcomes.

20 Jul 2021

IQWiG finds no benefit of high-flow therapy for COPD and type 1 respiratory failure

No benefit of high-flow therapy (HFT) can be derived from the available study data for patients with advanced chronic obstructive pulmonary disease (COPD) or chronic type 1 respiratory failure. It therefore remains unclear whether this form of treatment has advantages over long-term oxygen therapy (LTOT) or non-invasive ventilation (NIV).

20 Jul 2021

Study examines clinical outcomes in vaccinated individuals hospitalized with SARS-CoV-2 Delta variant

A new study has been published on the medRxiv* preprint server that has evaluated the clinical outcomes of the COVID-19 patients hospitalized in AIG hospitals, Hyderabad, India, between April 24, 2021, and May 31, 2021.

20 Jul 2021

With a diagnosis at last, Black women with ADHD start healing

Miché Aaron has always been a high achiever. The 29-year-old is in her third year of a planetary sciences doctoral program at Johns Hopkins University, where she researches minerals found on Mars. She's a former NASA space grant scholar and hopes to become an astronaut one day.

20 Jul 2021

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.

20 Jul 2021

T cells can be engineered to fight tumors without succumbing to exhaustion

Fighting a tumor is a marathon, not a sprint. For cancer-fighting T cells, the race is sometimes just too long, and the T cells quit fighting. Researchers even have a name for this phenomenon: T cell exhaustion.

19 Jul 2021

Exposure to woodland benefits adolescents’ cognition and mental health

Analysis of children and young people's proximity to woodlands has shown links with better cognitive development and a lower risk of emotional and behavioral problems, in research led by UCL and Imperial College London scientists that could influence planning decisions in urban areas.

19 Jul 2021

Chemical modification in RNA molecules may offer protection against liver disease

A chemical modification that occurs in some RNA molecules as they carry genetic instructions from DNA to cells' protein-making machinery may offer protection against non-alcoholic fatty liver, a condition that results from a build-up of fat in the liver and can lead to advanced liver disease, according to a new study by UCLA researchers.

19 Jul 2021

Novel robotic neck brace may help doctors to analyze neck mobility in cancer patients

A new robotic neck brace from researchers at Columbia Engineering and their colleagues at Columbia's Department of Otolaryngology may help doctors analyze the impact of cancer treatments on the neck mobility of patients and guide their recovery.

19 Jul 2021

Virginia Tech graduate student receives NSF grant to examine new treatments for pancreatic cancer

Jessica Gannon, a recent graduate in mechanical engineering at Virginia Tech, will continue her education and research as a doctoral student in biomedical engineering through Virginia Tech - Wake Forest University's School of Biomedical Engineering and Sciences.

19 Jul 2021

New compounds can provide a breakthrough in the treatment of neurodegenerative pathologies

Russian scientists have synthesized chemical compounds that can stop the degeneration of neurons in Alzheimer's, Parkinson's, and other severe brain pathologies. These substances can provide a breakthrough in the treatment of neurodegenerative pathologies.

19 Jul 2021

Tissue-specific genetic interactions drive different types of cancer development

Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium, the Technical University of Munich, and the University Medical Center Göttingen have now demonstrated that cells originating from different organs are differentially susceptible to activating mutations in cancer drivers: The same mutation in precursor cells of the pancreas or the bile duct leads to fundamental different outcomes.

19 Jul 2021

Therapy News and Research

Researchers identify immune protein linked to rare neurodegenerative disease

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

Experts develop consensus statement to help improve long-term well-being of people with HIV

Researchers use information theory to monitor resistance mechanisms to targeted cancer therapy

Pilot trial assesses sensory stimulation as a treatment for improving mobility in stroke survivors

World Brain Day 2021: An interview with Professor Alan Thompson

Study shows promise of combining radiation therapy with dendritic-cell vaccines for breast cancer

MET amplification identified as a potentially actionable driver for non-small cell lung cancer

Research reveals clues to how a molecule improves appearance of surgery scars

IQWiG finds no benefit of high-flow therapy for COPD and type 1 respiratory failure

Study examines clinical outcomes in vaccinated individuals hospitalized with SARS-CoV-2 Delta variant

With a diagnosis at last, Black women with ADHD start healing

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

T cells can be engineered to fight tumors without succumbing to exhaustion

Exposure to woodland benefits adolescents’ cognition and mental health

Chemical modification in RNA molecules may offer protection against liver disease

Novel robotic neck brace may help doctors to analyze neck mobility in cancer patients

Virginia Tech graduate student receives NSF grant to examine new treatments for pancreatic cancer

New compounds can provide a breakthrough in the treatment of neurodegenerative pathologies

Tissue-specific genetic interactions drive different types of cancer development

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News